Learning objectives
To discuss the basic principles, current clinical applications and challenges of dual-energy CT as quantitative imaging biomarkers in diffuse liver diseases.
Background
Diffuse liver diseases, including steatosis, iron overload, and fibrosis, have become a serious public health concern since they eventually progress to cirrhosis with increased risk for hepatocellular carcinoma. Accurate evaluation is important for optimizing management and predicting prognosis. Although liver biopsy can simultaneously assess fat, iron, and fibrosis, it has limitations including invasiveness, sampling errors, and interobserver variability. Dual-energy CT has been an alternative method for noninvasive assessment of diffuse liver diseases, potentially serving as ideal quantitative imaging biomarkers.
Findings and procedure details
Technical Background of Dual-Energy CT
1) Basic principles
CT imaging is based on the attenuation of an x-ray beam transmitted through the body, and the differentiation of various materials is based on their x-ray attenuation expressed CT numbers in Hounsfield units. The measured CT numbers of a voxel depend on its linear attenuation coefficient, which is not unique for any given material, but a function of the material composition, the x-ray energy, and the mass density of the material. Therefore, materials having different compositions can...
Conclusion
Dual-energy CT provides a quantitative assessment regarding the composition and degree of diffuse liver diseases. Understanding the utility and limitations of this technique is essential to achieve detailed information in diffuse liver diseases.
Personal information and conflict of interest
COI disclosure: None to disclose.
References
1. Mendonca PR, et al. IEEE Trans Med Imaging. 2014;33:99-116.
2.McCollough CH, et al.Radiology. 2015;276:637-53.
3.Patel BN, et al. J Comput Assist Tomogr. 2013;37:904-10.
4.Hyodo T, et al. Radiology. 2017;283:108-118.
5.Kramer H, et al. AJR Am J Roentgenol. 2017;208:92-100.
6.Luo XF, et al. Radiology. 2015;277:95-103.
7.Werner S, et al. Eur Radiol. 2019;29:2868-2877.
8. Kohgo Y, et al.J Gastroenterol Hepatol. 2008;23:S78-81.
9. Fischer MA, et al.Invest Radiol. 2011;46:351-8.
10.Zissen MH, et al. AJR Am J Roentgenol. 2013;201:1204-10.
11.Bandula S, et al. Radiology. 2015;275:136-43.
12. Varenika V,...